References
- Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 2003;42:1–36
- Gupta M, Goyal AK, Paliwal SR, et al. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res 2010;20:341–50
- Bidkar S, Jain D, Padsalg A, et al. Formulation development and evaluation of fluconazole gel in various polymer bases. Asian J Pharm 2007;1:63–8
- Bhalaria MK, Naik S, Misra AN. Ethosomes: a novel delivery system for antifungal drugs in treatment of topical fungal disease. Ind J Exp Biol 2009;47:368–75
- Agarwal R, Katare OP. Preparation and in-vitro evaluation of miconazole nitrate loaded topical liposomes. Pharm Tech 2002;preprint48–60 . Available from: http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/462002/38265/article.pdf [last accessed 13 March 2013]
- Sathali AAH, Rajalakhmi G. Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride. Int J Pharm Tech Res 2010;2:2081–9
- Hashem FM, Shaker DS, Ghorab MK, et al. Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery. AAPS Pharm Sci Tech 2011;12:879–86
- Souto EB, Muller RH. SLN and NLC for topical delivery of ketoconazole. J Microencapsul 2005;22:501–10
- Bachhav YG, Mondon K, Kalia YN, Gurny MM. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals. J Control Release 2011;153:126–32
- Rivera PA, Martinez-Oharriz MC, Rubio M, et al. Fluconazole encapsulation in PLGA microspheres by spray-drying. J Microencapsul 2004;21:203–11
- Ga De Jalón E, Blanco-Prieto MJ, Ygartua P, Santoyo S. PLGA microparticles: possible vehicles for topical drug delivery. Int J Pharm 2001;226:181–4
- Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475–90
- Ga De Jalon E, Blanco-Prieto MJ, Ygartua P, Santoyo S. Topical application of acyclovir loaded microparticles: quantification of the drug in porcine skin layers. J Control Release 2001;75:191–7
- Haddadi A, Farboud ES, Erfan M, Aboofazeli R. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery. J Microencapsul 2006;23:698–712
- Santoyo S, Ga De Jalón E, Ygartua P, et al. Optimization of topical cidofovir penetration using microparticles. Int J Pharm 2002;242:107–13
- Michael H, Manuela MG, Annelise EB, Ronald JN. Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds. Int J Pharm 2010;398:146–54
- Ulya B, Tangul S, Nilufer T. Microparticulate based topical delivery system of clobetasol propionate. AAPS Pharm Sci Tech 2011;12:949–57
- Souto EB, Muller RH. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul 2006;23:377–88
- Tiwari G. Biodegradable microspheres for controlled delivery of metronidazole in the treatment of periodontal diseases: formulation consideration. Int J Pharm Bio Sci 2010;1:1–13
- Maiti S, Dey P, Kaity S, et al. Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique. AAPS Pharm Sci Tech 2009;10:703–15
- Patel PR, Patel HH, Baria HA. Formulation and evaluation of carbopol gel containing liposomes of ketoconazole. Int J Drug Del Tech 2009;1:42–5
- Mohamed MI. Optimization of chlorphenesin emulgel formulation. AAPS J 2004;6:1–7
- Reddy MS, Mutalik S, Rao GV. Preparation and evaluation of minoxidil gels for topical application in alopecia. Ind J Pharm Sci 2006;68:432–6
- Satturwar PM, Fulzele SV, Dorle AK. Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: a technical note. AAPS PharmSciTech 2005;6:649–54
- Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci 2004;7:252–9
- Pierre MBR, Tedesco AC, Marchetti JM, Bentley MVL. Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in-vitro permeation study. BMC Dermatol 2001;1:5 . doi: 10.1186/1471-5945-1-5
- Barot BS, Parejiya BP, Patel HK, et al. Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using d-optimal design. AAPS Pharm Sci Tech 2012;13:184--92
- Zakir F, Vaidya B, Goyal AK, et al. Development and characterization of oleic acid vesicle for topical delivery of fluconazole. Drug Deliv 2010;17:238–48
- Maebashi K, Toyama T, Uchida K, Yamaguchi H. A novel model of cutaneous candidiasis produced in prednisolone-treated guinea pigs. J Med Vet Mycol 1995;19:390–2
- Gupta M, Vyas SP. Development, characterization and in-vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids 2012;165:454--61
- Zhang H, Gao S. Temozolomide/PLGA microparticles an dantitumor activity against glioma C6 cancer cells in-vitro. Int J Pharm 2007;329:122–8
- Gabor F, Ertl B, Wirth M, Mallinger R. Ketoprofen – poly(d,l-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J Microencapsul 1999;16:1–12
- Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in-vitro release profiles of biodegradable polymeric micro-spheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001;22:231–41
- Dobias B. Coagulation and flocculation: theory and applications. New York: M. Dekker; 1993
- Fu X, Ping Q, Gao Y. Effects of formulation factors on encapsulation efficiency and release behavior in-vitro of huperzine A-PLGA microspheres. J Microencapsul 2005;22:705–14